Rialto Wealth Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,450
Closed -$11.8K – 2029
2026
Q2
$11.8K Hold
1,450
– – ﹤0.01% 509
2026
Q1
$9.27K Hold
1,450
– – ﹤0.01% 476
2025
Q4
$8.63K Hold
1,450
– – ﹤0.01% 461
2025
Q3
$7.7K Hold
1,450
– – ﹤0.01% 449
2025
Q2
$4.97K Hold
1,450
– – ﹤0.01% 470
2025
Q1
$4.29K Buy
+1,450
New +$4.54K ﹤0.01% 464

Other funds holding PBYI

Rialto Wealth Management's PBYI Position: Q3 2026 in Review

Rialto Wealth Management sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 1,450 shares — an estimated $11.8K sold.

Rialto Wealth Management first reported a position in PBYI in Q1 2025 and held it in 6 quarters. The position peaked at $11.8K in Q2 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Rialto Wealth Management reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
  • Rialto Wealth Management sold 1,450 Puma Biotechnology shares in Q3 2026, an estimated $11.8K.
  • Rialto Wealth Management first reported a position in Puma Biotechnology in Q1 2025 and held it in 6 quarters.
  • Rialto Wealth Management's Puma Biotechnology position peaked at $11.8K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.